Skip to main content
Earnings Labs
ProKidney Corp. logo

ProKidney Corp. (PROK)

NASDAQ·Healthcare·Biotechnology

$1.18

+3.51%

Mkt Cap $358.11M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (5 analysts)

$4.67

Range $3.00 – $6.00

Implied Upside

+295.8%

Consensus $4.67 vs current $1.18